Last reviewed · How we verify
NCT05088148
Comparison of Pesticide and Pharmaceutical Contaminants Levels in Placenta and Cord Blood Samples of Pregnant Women With Fetal Growth Retardation and Healthy Pregnant Women
trial testing . Pesticide and Pharmaceutical analysis in Fetal Growth Retardation in 40 participants. Status unknown.
26 February 2023
Quick facts
| Lead sponsor | Kutahya Health Sciences University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 29 March 2022 |
| Primary completion | 26 February 2023 |
| Estimated completion | 26 March 2023 |
Drugs / interventions tested
- . Pesticide and Pharmaceutical analysis
Conditions studied
- Fetal Growth Retardation — all drugs for Fetal Growth Retardation →
Sponsor
Kutahya Health Sciences University
Who can join
Adults 18 to 40, female only, with Fetal Growth Retardation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim: In this study, pesticide and pharmaceutical contaminants levels in the placenta and cord blood of pregnant women with fetal growth retardation and healthy pregnant women will be compared in placenta and cord blood samples after delivery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05088148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fetal Growth Retardation
Currently open trials in the same condition.
- NCT06952777 — Validation of Sensors for Long-term Non-Invasive Fetal Monitoring · NA · recruiting
- NCT06405360 — DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development · NA · active not recruiting
- NCT06096805 — Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR) · recruiting
- NCT06215690 — Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction · active not recruiting
- NCT06416995 — Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes · recruiting
Other Kutahya Health Sciences University trials
Trials by the same sponsor.
- NCT07522658 — Artificial Intelligence-Generated vs Academician-Developed Multiple True/False Questions in Anesthesiology Education · not yet recruiting
- NCT07536685 — THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE · enrolling by invitation
- NCT07501416 — High-Intensity Laser Therapy in Hemiplegic Shoulder Pain · NA · not yet recruiting
- NCT07504887 — Effects of Aerobic Exercise in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460193 — CBCT and Audiological Analysis of the TMJ-Tinnitus Relationship · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05088148 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kutahya Health Sciences University
- Last refreshed: 1 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05088148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing